Back to Trades
Other4
Kailera Therapeutics, Inc.
KLRA
Total Value
$0
Company Information
- Company Name
- Kailera Therapeutics, Inc.
- Ticker Symbol
- KLRA
- CIK
- 0002096997
Insider Information
- Role
- 10% Owner
10% Owner
Filing Details
- Filing Date
- Apr 22, 2026
- Transaction Date
- Apr 20, 2026
- Accession Number
- 0001104659-26-046276
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | 9,477,719 | — | C | — |
| Apr 20, 2026 | Common Stock | 2,034,133 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Derivative | 4,968,789 | — | C | — |
| Apr 20, 2026 | Derivative | 708,814 | — | C | — |
Footnotes
- (F1)The reported securities are directly held by Hengrui (USA) Ltd. Hengrui (USA) Ltd. is a wholly-owned subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- (F2)The Series A-2 convertible preferred stock and Series A-2 convertible non-voting preferred stock (collectively, the "Preferred Stock") of the Issuer are convertible into shares of Common Stock of the Issuer at the holder's election and have no expiration date. All shares of the Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock.